Norris Medicines

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE744C01029
NSEID:
BSEID: 524414

INR

16.30

0.3 (1.88%)

BSENSE

Apr 11, 12:34 PM

BSE+NSE Vol: 858

{
  "main_header": {
    "sid": 210607,
    "name": "Norris Medicines",
    "stock_name": "Norris Medicines",
    "full_name": "Norris Medicines Ltd",
    "name_url": "stocks-analysis/norris-medicines",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "16.30",
    "chg": 0.3,
    "chgp": "1.88%",
    "dir": 1,
    "prev_price": "16.00",
    "mcapval": "16.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524414,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE744C01029",
    "curr_date": "Apr 11, 12:34 PM",
    "curr_time": "01:24 AM",
    "bse_nse_vol": "858 ",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/norris-medicines-210607-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Norris Medicines Ltd Experiences Increased Buying Amid Recent Price Declines and Sector Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-declines-0-43-today-faces-14-91-monthly-drop-despite-yearly-13-38-gain-1697725",
        "imagepath": "",
        "date": "2025-04-03 12:40:07",
        "description": "Norris Medicines Ltd is currently witnessing strong buying activity, despite a recent trend of consecutive losses. The stock has experienced a decline of 0.43% today, underperforming the Sensex, which fell by 0.34%. Over the past week, Norris Medicines has seen a significant drop of 6.44%, compared to the Sensex's decline of 1.61%. In the last month, the stock has decreased by 14.91%, while the Sensex has gained 4.47%.\n\nNotably, Norris Medicines has been on a downward trajectory for the past three days, accumulating a total loss of 9.61%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. \n\nDespite these challenges, the broader Pharmaceuticals & Drugs sector has shown resilience, gaining 2.23%. This sector performance may be contributing to the buying pressure on Norris Medicines, as investors may be looking for opportunities wit..."
      },
      {
        "title": "Norris Medicines Ltd Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-selling-pressure-with-7-21-decline-amid-ongoing-losses-1678650",
        "imagepath": "",
        "date": "2025-04-02 14:45:05",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, resulting in a total decline of 9.22%. Today, the stock opened with a gap down of 2.84% and reached an intraday low of Rs 16.34, reflecting a 7.21% drop. \n\nIn terms of performance relative to the Sensex, Norris Medicines has underperformed across various time frames. Over the past week, the stock has declined by 6.09%, while the Sensex fell only 0.97%. In the last month, Norris Medicines has seen a significant drop of 16.63%, contrasting sharply with the Sensex's gain of 4.56%. Year-to-date, the stock is down 5.82%, compared to the Sensex's decline of 2.05%. \n\nThe stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Contributing factors to this selling p..."
      },
      {
        "title": "Norris Medicines Ltd Sees Strong Buying Activity Amid Recent Price Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-declines-1-09-today-yet-gains-26-47-over-past-year-1657540",
        "imagepath": "",
        "date": "2025-04-01 10:15:18",
        "description": "Norris Medicines Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is currently witnessing strong buying activity despite a recent decline in its stock price. Today, the stock has recorded a decrease of 1.09%, while the benchmark Sensex has fallen by 0.70%. Over the past week, Norris Medicines has seen a more significant drop of 8.07%, contrasting with a slight gain of 0.20% in the Sensex.\n\nIn terms of longer-term performance, Norris Medicines has experienced a notable increase of 26.47% over the past year, significantly outperforming the Sensex's 4.63% rise. However, the stock has struggled in the short term, with a 12.24% decline over the past month compared to the Sensex's 5.28% gain. \n\nThe stock's price summary indicates that it opened with a gap up but is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This trend may suggest underlying market dynamic..."
      },
      {
        "title": "Norris Medicines Faces Intense Selling Pressure Amid Continued Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-selling-pressure-with-8-16-monthly-loss-amid-ongoing-declines-1641970",
        "imagepath": "",
        "date": "2025-03-28 11:15:06",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of losses, as the company has experienced four consecutive days of declines. Over the past week, Norris Medicines has dropped by 3.79%, contrasting with a slight gain of 0.88% in the Sensex. The stock's performance over the past month reveals a more pronounced decline of 8.16%, while the Sensex has risen by 5.99% during the same period.\n\nDespite the recent downturn, Norris Medicines has shown resilience over the longer term, with a year-to-date performance of 3.75%, outperforming the Sensex, which has declined by 0.71%. Additionally, the stock has gained an impressive 32.35% over the past year, significantly outpacing the Sensex's 5.34% increase. \n\nThe price summary indicates that Norris Medicines has outperformed its sector by 3.64% today, although it remains bel..."
      },
      {
        "title": "Norris Medicines Faces Intense Selling Pressure Amid Consecutive Losses and Market Disconnect",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-significant-selling-pressure-with-4-45-weekly-loss-and-13-05-monthly-decline-1624447",
        "imagepath": "",
        "date": "2025-03-27 11:15:06",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past four days, resulting in a total decline of 7.06%. In terms of daily performance, Norris Medicines fell by 0.06%, while the benchmark Sensex gained 0.50%. \n\nOver the past week, the stock has dropped 4.45%, contrasting sharply with the Sensex's increase of 1.74%. The one-month performance reveals a more pronounced decline of 13.05% for Norris Medicines, compared to the Sensex's positive return of 4.11%. Despite a strong year-over-year performance of 34.08%, which outpaces the Sensex's 6.41%, the recent trend indicates a struggle for the microcap pharmaceutical company.\n\nNorris Medicines is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish sentiment in the market. The stock's per..."
      },
      {
        "title": "Norris Medicines Ltd Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-significant-selling-pressure-declines-11-20-over-one-month-1600054",
        "imagepath": "",
        "date": "2025-03-26 09:40:08",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, raising concerns among market observers. Over the past week, Norris Medicines has declined by 7.50%, while the Sensex has gained 3.31%. The one-month performance reflects a similar pattern, with the stock down 11.20% compared to the Sensex's increase of 4.49%.\n\nIn the short term, Norris Medicines has underperformed relative to the broader market, with a three-month decline of 1.55% against the Sensex's slight drop of 0.67%. However, the stock has shown resilience over the longer term, with a one-year gain of 38.10% compared to the Sensex's 7.56% increase. Year-to-date, Norris Medicines is up 2.36%, while the Sensex has seen a marginal decline of 0.24%. \n\nCurrently, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 20..."
      },
      {
        "title": "Norris Medicines Ltd Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-selling-pressure-with-4-76-decline-amid-ongoing-losses-1580691",
        "imagepath": "",
        "date": "2025-03-25 11:35:04",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, with a decline of 4.81% during this period. In terms of daily performance, Norris Medicines fell by 4.76%, contrasting sharply with the Sensex, which recorded a modest gain of 0.09%.\n\nOver the past week, the stock has dropped 3.94%, while the Sensex has risen by 3.65%. The one-month performance reveals a more pronounced decline of 11.00% for Norris Medicines, compared to a 4.62% increase in the Sensex. Despite a strong one-year performance of 44.72% against the Sensex's 7.17%, the recent trends indicate a troubling shift.\n\nThe stock's performance relative to key moving averages shows it is currently above the 200-day moving average but below the 5-day, 20-day, 50-day, and 100-day averages. This suggests a potential weakening ..."
      },
      {
        "title": "Norris Medicines Ltd Faces Intensified Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-selling-pressure-with-6-87-monthly-decline-amid-weak-performance-1574000",
        "imagepath": "",
        "date": "2025-03-24 10:35:07",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, highlighting a challenging period for the microcap pharmaceutical company. \n\nIn terms of performance, Norris Medicines has underperformed relative to the Sensex, with a decline of 0.05% today compared to the Sensex's gain of 0.93%. Over the past week, the stock has gained 0.92%, but this is notably lower than the Sensex's increase of 4.65%. The one-month performance reveals a more concerning trend, with Norris Medicines down 6.87%, while the Sensex has risen by 4.25%. \n\nDespite a strong year-to-date performance of 7.78% against the Sensex's decline of 0.67%, the stock's recent trajectory raises questions. The price summary indicates that Norris Medicines is currently higher than its 5-day and 200-day moving averages but lower than it..."
      },
      {
        "title": "Norris Medicines Faces Intense Selling Pressure Amid Consecutive Losses and Bearish Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/norris-medicines-ltd-faces-significant-selling-pressure-with-8-85-total-decline-over-two-days-1546443",
        "imagepath": "",
        "date": "2025-03-21 10:30:06",
        "description": "Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, resulting in a total decline of 8.85%. This trend is particularly notable as the stock has underperformed its sector by 4.71% today.\n\nIn terms of performance relative to the Sensex, Norris Medicines has shown mixed results. While the stock gained 59.12% over the past year compared to the Sensex's 5.48%, it has struggled recently, with a 6.69% decline over the past month, while the Sensex rose by 1.74%. Over the last week, Norris Medicines saw a 4.14% increase, outperforming the Sensex's 3.78% gain.\n\nCurrently, Norris Medicines is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The combination of these factors suggests a challenging environment for the microcap pharmac..."
      }
    ],
    "total": 48,
    "sid": "210607",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/norris-medicines-210607"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "04-Apr-2025",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Mar-2025",
      "details": "As per attachment.",
      "source": "BSE"
    },
    {
      "caption": "Integrated Filing (Financial)",
      "datetime": "14-Feb-2025",
      "details": "As per attachment.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Norris Medicines Ltd Experiences Increased Buying Amid Recent Price Declines and Sector Resilience

2025-04-03 12:40:07

Norris Medicines Ltd is currently witnessing strong buying activity, despite a recent trend of consecutive losses. The stock has experienced a decline of 0.43% today, underperforming the Sensex, which fell by 0.34%. Over the past week, Norris Medicines has seen a significant drop of 6.44%, compared to the Sensex's decline of 1.61%. In the last month, the stock has decreased by 14.91%, while the Sensex has gained 4.47%. Notably, Norris Medicines has been on a downward trajectory for the past three days, accumulating a total loss of 9.61%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite these challenges, the broader Pharmaceuticals & Drugs sector has shown resilience, gaining 2.23%. This sector performance may be contributing to the buying pressure on Norris Medicines, as investors may be looking for opportunities wit...

Norris Medicines Ltd Faces Intense Selling Pressure Amid Consecutive Losses

2025-04-02 14:45:05

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, resulting in a total decline of 9.22%. Today, the stock opened with a gap down of 2.84% and reached an intraday low of Rs 16.34, reflecting a 7.21% drop. In terms of performance relative to the Sensex, Norris Medicines has underperformed across various time frames. Over the past week, the stock has declined by 6.09%, while the Sensex fell only 0.97%. In the last month, Norris Medicines has seen a significant drop of 16.63%, contrasting sharply with the Sensex's gain of 4.56%. Year-to-date, the stock is down 5.82%, compared to the Sensex's decline of 2.05%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Contributing factors to this selling p...

Norris Medicines Ltd Sees Strong Buying Activity Amid Recent Price Fluctuations

2025-04-01 10:15:18

Norris Medicines Ltd, a microcap player in the Pharmaceuticals & Drugs sector, is currently witnessing strong buying activity despite a recent decline in its stock price. Today, the stock has recorded a decrease of 1.09%, while the benchmark Sensex has fallen by 0.70%. Over the past week, Norris Medicines has seen a more significant drop of 8.07%, contrasting with a slight gain of 0.20% in the Sensex. In terms of longer-term performance, Norris Medicines has experienced a notable increase of 26.47% over the past year, significantly outperforming the Sensex's 4.63% rise. However, the stock has struggled in the short term, with a 12.24% decline over the past month compared to the Sensex's 5.28% gain. The stock's price summary indicates that it opened with a gap up but is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This trend may suggest underlying market dynamic...

Norris Medicines Faces Intense Selling Pressure Amid Continued Price Declines

2025-03-28 11:15:06

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of losses, as the company has experienced four consecutive days of declines. Over the past week, Norris Medicines has dropped by 3.79%, contrasting with a slight gain of 0.88% in the Sensex. The stock's performance over the past month reveals a more pronounced decline of 8.16%, while the Sensex has risen by 5.99% during the same period. Despite the recent downturn, Norris Medicines has shown resilience over the longer term, with a year-to-date performance of 3.75%, outperforming the Sensex, which has declined by 0.71%. Additionally, the stock has gained an impressive 32.35% over the past year, significantly outpacing the Sensex's 5.34% increase. The price summary indicates that Norris Medicines has outperformed its sector by 3.64% today, although it remains bel...

Norris Medicines Faces Intense Selling Pressure Amid Consecutive Losses and Market Disconnect

2025-03-27 11:15:06

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past four days, resulting in a total decline of 7.06%. In terms of daily performance, Norris Medicines fell by 0.06%, while the benchmark Sensex gained 0.50%. Over the past week, the stock has dropped 4.45%, contrasting sharply with the Sensex's increase of 1.74%. The one-month performance reveals a more pronounced decline of 13.05% for Norris Medicines, compared to the Sensex's positive return of 4.11%. Despite a strong year-over-year performance of 34.08%, which outpaces the Sensex's 6.41%, the recent trend indicates a struggle for the microcap pharmaceutical company. Norris Medicines is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish sentiment in the market. The stock's per...

Norris Medicines Ltd Faces Intense Selling Pressure Amid Consecutive Losses

2025-03-26 09:40:08

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, raising concerns among market observers. Over the past week, Norris Medicines has declined by 7.50%, while the Sensex has gained 3.31%. The one-month performance reflects a similar pattern, with the stock down 11.20% compared to the Sensex's increase of 4.49%. In the short term, Norris Medicines has underperformed relative to the broader market, with a three-month decline of 1.55% against the Sensex's slight drop of 0.67%. However, the stock has shown resilience over the longer term, with a one-year gain of 38.10% compared to the Sensex's 7.56% increase. Year-to-date, Norris Medicines is up 2.36%, while the Sensex has seen a marginal decline of 0.24%. Currently, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 20...

Norris Medicines Ltd Faces Intense Selling Pressure Amid Consecutive Losses

2025-03-25 11:35:04

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, with a decline of 4.81% during this period. In terms of daily performance, Norris Medicines fell by 4.76%, contrasting sharply with the Sensex, which recorded a modest gain of 0.09%. Over the past week, the stock has dropped 3.94%, while the Sensex has risen by 3.65%. The one-month performance reveals a more pronounced decline of 11.00% for Norris Medicines, compared to a 4.62% increase in the Sensex. Despite a strong one-year performance of 44.72% against the Sensex's 7.17%, the recent trends indicate a troubling shift. The stock's performance relative to key moving averages shows it is currently above the 200-day moving average but below the 5-day, 20-day, 50-day, and 100-day averages. This suggests a potential weakening ...

Norris Medicines Ltd Faces Intensified Selling Pressure Amid Consecutive Losses

2025-03-24 10:35:07

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. This trend marks a continuation of consecutive days of losses, highlighting a challenging period for the microcap pharmaceutical company. In terms of performance, Norris Medicines has underperformed relative to the Sensex, with a decline of 0.05% today compared to the Sensex's gain of 0.93%. Over the past week, the stock has gained 0.92%, but this is notably lower than the Sensex's increase of 4.65%. The one-month performance reveals a more concerning trend, with Norris Medicines down 6.87%, while the Sensex has risen by 4.25%. Despite a strong year-to-date performance of 7.78% against the Sensex's decline of 0.67%, the stock's recent trajectory raises questions. The price summary indicates that Norris Medicines is currently higher than its 5-day and 200-day moving averages but lower than it...

Norris Medicines Faces Intense Selling Pressure Amid Consecutive Losses and Bearish Trends

2025-03-21 10:30:06

Norris Medicines Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, resulting in a total decline of 8.85%. This trend is particularly notable as the stock has underperformed its sector by 4.71% today. In terms of performance relative to the Sensex, Norris Medicines has shown mixed results. While the stock gained 59.12% over the past year compared to the Sensex's 5.48%, it has struggled recently, with a 6.69% decline over the past month, while the Sensex rose by 1.74%. Over the last week, Norris Medicines saw a 4.14% increase, outperforming the Sensex's 3.78% gain. Currently, Norris Medicines is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The combination of these factors suggests a challenging environment for the microcap pharmac...

View All News